A Trial Evaluating Vitamin D Normalization on Major Adverse Cardiovascular-Related Events Among Myocardial Infarction Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 634 participants.
Also called NCT02996721
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 634 participants
- Registry
-
NCT02996721
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02996721. Randomized; no masking; primary purpose treatment. Start 2017-04-03 (actual); primary completion 2025-03-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Trial Evaluating Vitamin D Normalization on Major Adverse Cardiovascular-Related Events Among Myocardial Infarction Patients
- Acronym
- TARGET-D
- Condition
- Death
- Condition
- Myocardial Infarction
- Condition
- Cerebral Vascular Accident
- Condition
- Heart Failure Hospitalization
- Intervention (Biological)
- Vitamin D3
- Lead sponsor
- Intermountain Health Care, Inc.
Record details
- Record id
cardio:ct-nct02996721- Content hash
1cdfbd50ffc1bb0b752ac94290693e079e59c6188af012e891d8010bd8e214cf